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Double-stranded RNA (dsRNA) is a by-product of viral RNA polymerase activity, and its recognition is one
mechanism by which the innate immune system is activated. Cellular responses to dsRNA include induction
of alpha/beta interferon (IFN) synthesis and activation of the enzyme PKR, which exerts its antiviral effect by
phosphorylating the eukaryotic initiation factor eIF-2 alpha, thereby inhibiting translation. We have recently
identified the nonstructural protein NSs of Bunyamwera virus (BUNV), the prototype of the family Bunyaviridae,
as a virulence factor that blocks the induction of IFN by dsRNA. Here, we investigated the potential of NSs to
inhibit PKR. We show that wild-type (wt) BUNV that expresses NSs triggered PKR-dependent phosphorylation
of eIF-2 alpha to levels similar to those of a recombinant virus that does not express NSs (BUNdelNSs virus).
Furthermore, the sensitivity of viruses in cell culture to IFN was independent of PKR and was not determined
by NSs. PKR knockout mice, however, succumbed to infection approximately 1 day earlier than wt mice or mice
deficient in expression of RNase L, another dsRNA-activated antiviral enzyme. Our data indicate that (i)
bunyaviruses activate PKR, but are only marginally sensitive to its antiviral effect, and (ii) NSs is different from
other IFN antagonists, since it inhibits dsRNA-dependent IFN induction but has no effect on the dsRNA-
activated PKR and RNase L systems.
The family Bunyaviridae is a large group of viruses which
contains more than 300 named virus isolates (7). They are
mainly transmitted by arthropods, and several members cause
encephalitis, febrile illnesses, or hemorrhagic fevers, e.g., La
Crosse, Oropouche, Hantaan, Rift Valley fever, and Crimean-
Congo hemorrhagic fever viruses, in humans (8). The family
has been classified into five genera: Bunyavirus, Hantavirus,
Nairovirus, Phlebovirus, and Tospovirus. The prototype of both
the family Bunyaviridae and the genus Bunyavirus is Bunyam-
wera virus (BUNV), and this is the only family member to date
that has been rescued from cloned cDNAs (3). All bunyavi-
ruses are enveloped and have a trisegmented, single-stranded
RNA genome of negative polarity, replicate in the cytoplasm,
and bud into the Golgi apparatus (7). They encode four com-
mon structural proteins: the viral polymerase (L) on the large
(L) segment, two glycoproteins (G1 and G2) on the medium
(M) segment, and the viral nucleocapsid protein (N) on the
smallest (S) segment. Viruses within some genera also encode
nonstructural proteins, either on the M segment (termed
NSm) or on the S segment (NSs).
Alpha/beta interferons (IFN- and -) are a major compo-
nent of the innate immune system. As a reaction to virus
infection, cells synthesize and secrete IFNs that initiate syn-
thesis of antiviral proteins in the target cell, thus establishing
an antiviral state (20). Induction of IFN occurs at the level of
transcriptional initiation and requires several regulatory fac-
tors that can be activated by different triggers, the most im-
portant being double-stranded RNA (dsRNA), a by-product of
viral RNA polymerases. To combat different types of viruses,
multiple, partially redundant pathways have evolved that in-
hibit different stages of virus replication. The best character-
ized antiviral factors induced by IFN- and - are the Mx
proteins (12), the 2-5 oligoadenylate synthetase (2-5 OAS)/
RNase L system (19), and the protein kinase R (PKR) (24). Mx
proteins are large GTPases that inhibit the multiplication of
several RNA viruses, including representative members of the
Bunyavirus, Hantavirus, and Phlebovirus genera within the Bu-
nyaviridae family (9, 13–15, 18). For La Crosse virus, which is
closely related to BUNV, it has been shown that the Mx pro-
tein sequesters the N protein, thereby depleting the viral RNA
synthesis machinery from a factor that is essential for replicat-
ing the genome (16). By contrast, little is known about the
activity of 2-5 OAS/RNase L and PKR against bunyaviruses.
Both systems are constitutively expressed in the cell, upregu-
lated by IFN, and become activated following interaction with
dsRNA. The 2-5 OAS catalyzes the synthesis of short 2-5
oligoadenylates that activate the latent endoribonuclease
RNase L. RNase L, in turn, then degrades both viral and
cellular RNAs, thus inhibiting viral replication (27). PKR is a
serine-threonine kinase that phosphorylates the  subunit of
eukaryotic translation initiation factor eIF2, thereby seques-
tering the recycling factor, eIF2B/GEF (20). As a consequence,
translation of cellular and viral mRNAs is inhibited. Thus, the
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effector proteins activated by IFN protect the host by blocking
replication, transcription, or translation of viral genes.
Viruses have evolved different compensatory defense mech-
anisms to block either IFN induction, IFN signal transduction,
or the action of particular antiviral proteins (10, 11). Promi-
nent examples of such IFN antagonists are the NS1 protein of
influenza A virus (FLUAV) (10) and the E3L protein of pox-
viruses (5, 25), which are dsRNA binding proteins. Thus, NS1
and E3L not only interfere with synthesis of IFN but also
increase resistance to IFN by inhibiting activation of the PKR/
2-5 OAS systems. It was reported recently that the NSs protein
of BUNV inhibits the production of IFN in infected cells (23).
A recombinant BUNV was generated that does not express the
NSs protein (4), and it was demonstrated that this virus, named
BUNdelNSs, but not the wild-type (wt) BUNV counterpart, is
a strong inducer of IFN- and -. Consequently, BUNdelNSs
virus replicated to levels similar to those of wt BUNV in both
cells and mice lacking a functional IFN- and - system but
was restricted in IFN-competent systems. IFN induction by
BUNdelNSs virus was found to involve virally produced
dsRNA and the dsRNA-activated transcription factors NF-B
and IRF-3. Furthermore, transiently expressed NSs was found
to be sufficient to inhibit activation of an IFN promoter by
dsRNA, indicating that NSs can act independently of viral
replication, somehow interfering with the signal transduction
pathway that is activated by dsRNA.
Here, we investigated whether BUNV NSs behaves in a
manner similar to that of other IFN antagonists and—besides
inhibiting the dsRNA-dependent IFN induction—inhibits also
the activation of the dsRNA-dependent PKR enzyme. Further-
more, the general sensitivity of BUNV against IFN, and in
particular against the dsRNA-dependent effectors PKR and
2-5 OAS, was evaluated.
Activation of PKR. To investigate whether BUNV NSs
would influence PKR, we assayed phosphorylation of the eu-
karyotic translation factor eIF-2 in infected cells. Murine
embryonic fibroblasts (MEFs) derived from wt 129 mice (kind-
ly donated by Jovan Pavlovic, University of Zurich, Switzer-
land) were either mock infected or infected with wt BUNV or
BUNdelNSs virus or transfected with dsRNA as a positive
control. The phosphorylation of eIF-2 was detected by im-
munoblot analysis of the cell lysates. Figure 1A (upper row)
shows that wt BUNV, BUNdelNSs virus, and transfected
dsRNA induce eIF-2 phosphorylation, whereas in untreated
cells, no signal was detected. wt BUNV induced eIF-2 phos-
phorylation to a lower level than dsRNA or BUNdelNSs virus.
PKR expression, however, was elevated in BUNdelNSs-in-
fected and in dsRNA-treated cells, whereas wt BUNV-infected
cells contained amounts of PKR similar to that of the mock-
treated control (Fig. 1A, middle row). The actin control dem-
onstrates that comparable amounts of protein were used in all
lanes (Fig. 1A, lower row). As an additional control, we veri-
fied that neither wt BUNV, BUNdelNSs virus, nor dsRNA was
able to induce a change in eIF-2 phosphorylation in cells
derived from PKR knockout mice (data not shown). Thus,
induction of eIF-2 phosphorylation by wt BUNV and
BUNdelNSs virus requires dsRNA-dependent PKR and is a
reliable marker of PKR activity in this system.
Increased PKR expression and eIF-2 phosphorylation in
BUNdelNSs-infected cells relative to wt BUNV-infected cells
most probably resulted from IFN induced by the BUNdelNSs
virus. To determine whether this was the case, we investigated
eIF-2 phosphorylation in MEF cells unresponsive to IFN due
to absence of the IFN-/ receptor [IFNAR(/) MEFs]
(17). In Fig. 1B (upper row), it is shown that eIF-2 phosphor-
ylation was similar in IFNAR(/) MEFs infected with wt
BUNV or BUNdelNSs virus or those treated with dsRNA,
whereas in mock-treated cells, no such signal could be de-
tected. Furthermore, PKR was expressed to similar levels (Fig.
1B, middle row), as was actin (Fig. 1B, lower row), suggesting
that elevated PKR expression observed in wt cells was indeed
due to IFN induced by BUNdelNSs virus or dsRNA and that
this resulted in increased eIF-2 phosphorylation.
Taken together, these data suggest that BUNV produces
dsRNA that activates PKR, which in turn leads to eIF-2
phosphorylation, and that the bunyavirus virulence factor NSs
does not possess an activity to inhibit these events.
Effect of IFN and PKR on bunyavirus growth in cell culture.
To determine whether NSs can contribute to resistance against
the antiviral action of IFN, we compared the growth of wt
BUNV and BUNdelNSs virus in IFN-treated cells. For these
FIG. 1. Activation of PKR in infected wt (A) or IFNAR(/)
(B) cells. Cells were either mock infected (lanes m), infected with 5
PFU/cell of wt BUNV (lanes wt) or BUNdelNSs virus (lanes delNSs),
or transfected with 10 g of poly(I-C) (lanes dsRNA). After 16 h, cells
were lysed in buffer containing 50 mM Tris-HCl (pH 8), 150 mM NaCl,
1% NP-40, 0.25% Na-deoxycholate, 0.1% sodium dodecyl sulfate, 1
mM dithiothreitol, 10 mM NaF, 0.25 mM NaVO4, and protease inhib-
itor cocktail mix (Roche). Lysates (10 g of protein per lane) were
assayed by Western blot analysis with antibodies against phosphory-
lated eIF-2 (1:200 dilution of rabbit anti-eIF-2 [pS51]; Biosource
International), PKR (1:200 dilution of mouse monoclonal antibody
B-10; Santa Cruz Biotechnology), or actin as a control (1:500 dilution
of mouse monoclonal antibody AC-40; Sigma). Protein bands were
visualized using the ECL method (Amersham).
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assays, we chose Vero cells because they are unable to synthe-
size IFN but are fully responsive to IFN treatment (6), thus
excluding any additional effects of virus-induced IFN that
would bias the results. Cells were pretreated with increasing
doses of IFN- and - (10 to 1,000 IU/ml) and infected with
virus, and infectious virus in the supernatant was determined
after overnight incubation. As expected (4), wt BUNV had an
approximately 10-fold-higher titer than BUNdelNSs virus in
cells not treated with IFN. When increasing amounts of IFN
were added, significant reductions of virus yields were ob-
served. If plotted on a double logarithmic scale (Fig. 2A), titers
of both wt BUNV and BUNdelNSs virus decreased linearly
with a slope of approximately 0.7; i.e., a 10-fold increase in
IFN concentration resulted in an 0.7-fold decrease of log10
virus titer. Since both lines appear parallel to each other, we
conclude that both viruses have a similar sensitivity to IFN.
Thus, BUNV is sensitive to the antiviral effects of IFN in Vero
cells, and the NSs protein does not confer IFN resistance.
Next we investigated the anti-bunyavirus activity of PKR. To
this aim, we measured the IFN effect in wt cells and MEF cells
derived from PKR knockout mice [PKR(/) MEFs], kindly
donated by Jovan Pavlovic, University of Zurich, Switzerland.
Cells were incubated with IFN prior to infection, and virus
growth was compared to that in untreated cells. A neutralizing
anti-IFN antiserum was added to the supernatants of the un-
treated controls to exclude the effect of virus-induced IFN
which would inhibit growth of BUNdelNSs (23). Furthermore,
to exclude potential carryover effects of the IFN present in
the supernatants of treated cells, we used IFN-insensitive
IFNAR(/) MEFs for titrations. In Fig. 2B (columns 1 to 4),
it is shown that in PKR-expressing wt cells, both wt BUNV and
BUNdelNSs virus were inhibited to similar extents by IFN.
Surprisingly, IFN also displayed an inhibitory effect against
both viruses on PKR(/) cells that was not essentially dif-
ferent from that on wt cells (Fig. 2B, columns 5 to 8). Further-
more, only slightly higher titers were observed in the mutant
cells relative to those in wt cells, despite the absence of PKR.
We therefore investigated growth of the PKR-sensitive vesic-
ular stomatitis virus (VSV) in our MEF cells. Similar to the
situation with the bunyaviruses, no apparent contribution of
PKR to the IFN effect was detected (data not shown). This
suggests that the levels of activated PKR in our MEF cells are
not sufficient to inhibit virus growth significantly. Taken to-
gether, these data indicate that, in MEF cells, BUNV is not
sensitive to PKR action and that this mechanism is indepen-
dent from the NSs virulence factor.
Effect of PKR and 2-5 OAS systems in vivo. We investigated
whether PKR has an in vivo effect against bunyaviruses by
comparing survival of infected wt 129 mice and their PKR-
deficient counterparts (26). Furthermore, we included mice
lacking the 2-5 OAS system (27) to address the role of this
dsRNA-dependent enzyme with respect to bunyavirus patho-
genesis. Groups of mice expressing PKR (PKR 129 wt mice) or
mice lacking PKR [PKR(/) mice] or the 2-5 OAS system
[RNase L(/) mice] were inoculated intracerebrally with wt
BUNV and observed for survival. Figure 3A shows that wt
mice were killed within 5 days, as expected (4, 23). By contrast,
mice lacking PKR succumbed to disease approximately 1 day
earlier, suggesting that PKR has a certain protective effect
against wt BUNV in vivo. Surprisingly, however, mice deficient
in RNase L expression displayed no difference from wt mice
with respect to disease progression, indicating that the 2-5
OAS system has no anti-bunyaviral activity. To determine
whether the BUNV NSs virulence factor had any influence on
the action of either PKR or 2-5 OAS in vivo, we infected wt
and knockout mice in parallel with the BUNdelNSs mutant
virus. As expected, the BUNdelNSs virus displayed a difference
in onset of disease compared to wt BUNV (Fig. 3B), presum-
ably due to the IFN induced by the NSs-deficient mutant (23).
With respect to the sensitivity to PKR and 2-5 OAS, however,
the situation was similar to that for wt BUNV, since
PKR(/) mice succumbed to disease between 1 and 2 days
earlier than wt mice, whereas for the RNase L-deficient mice,
FIG. 2. Effect of IFN and PKR in cell culture. (A) Vero cells were
grown to 80% confluence and incubated overnight with various con-
centrations of human interferon alpha A/D (BglII) (PBL Biomedical
Laboratories). After 24 h of incubation, cells were infected with 0.01
PFU/cell of wt BUNV or BUNdelNSs virus and incubated in Dulbec-
co’s modified Eagle medium–10% fetal calf serum, again containing
IFN. Virus yields were measured 18 h postinfection in plaque assays, as
described previously (22). (B) IFN sensitivity of viruses in wt cells
(columns 1 to 4) or PKR(/) MEF cells (columns 5 to 8). Cells were
treated either with 1,000 neutralizing units of sheep polyclonal anti-
mouse IFN-/ (PBL Biomedical Laboratories) or with 1,000 units of
IFN- and - for 24 h, infected with 0.01 PFU/cell of wt BUNV
(columns 1, 2, 5, and 6) or BUNdelNSs virus (columns 3, 4, 7, and 8),
and incubated in Dulbecco’s modified Eagle medium–10% fetal calf
serum, again containing IFN. Virus yields were measured 18 h postin-
fection with MEFs derived from IFN-/ receptor knockout mice.
Averages and standard deviations of results of three independent ex-
periments are shown.
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again there was no difference (Fig. 3B). To further investigate
how PKR may affect virus growth in vivo, we determined the
virus titers in brains of wt and PKR(/) animals (Table 1).
As observed in cell culture (see Fig. 2B), wt BUNV grew to
similar titers in wt mice and PKR(/) mice at day 3 postin-
fection. By contrast, growth of BUNdelNSs virus was inhibited
by approximately 2 log steps in wt mice, but not in PKR(/)
animals. This difference is most probably due to the IFN in-
duced by the delNSs virus, which leads to increased expression
of PKR in wt animals (see Fig. 1A), again suggesting that PKR
has a certain anti-bunyaviral effect in vivo.
Taken together, these results indicate that of the antiviral
systems that are activated by dsRNA, PKR, but not 2-5 OAS,
has a weak protective effect against BUNV in vivo. Further-
more, as demonstrated in cell culture, the NSs virulence factor
does not contribute to viral resistance against any of these IFN
effectors.
In this study, multiple aspects of bunyavirus interaction with
the IFN system were investigated. Firstly, we demonstrated
that the BUNV NSs protein, which was previously identified as
a factor counteracting IFN induction (23), does not appear to
interfere with activation of the antiviral enzyme PKR. Sec-
ondly, NSs does not influence the IFN sensitivity of the vi-
rus. Thirdly, although both wt BUNV and the NSs-deficient
BUNdelNSs mutant activate PKR, a contribution of PKR to
host resistance could be observed only in vivo. Lastly, the 2-5
OAS has no antiviral effect in vivo against either wt BUNV or
BUNdelNSs virus.
Many viruses, e.g., influenza viruses and poxviruses, have
evolved mechanisms to counteract both IFN induction and
IFN action by sequestering of dsRNA (reviewed in references
10 and 11). In previous studies, the BUNV NSs protein ap-
peared to act by a similar mechanism, since (i) infection with
the BUNdelNSs mutant, but not with the NSs-expressing wt
virus, led to a dsRNA-dependent induction of IFN, and (ii)
NSs expressed in cell culture was able to inhibit dsRNA-me-
diated activation of an IFN promoter (23). Here, we clarified
whether NSs also interferes with the dsRNA-activated IFN
effectors PKR and 2-5 OAS. Surprisingly, NSs was unable to
inhibit PKR activation (Fig. 1). Neither did NSs enhance virus
resistance to IFN, since both wt BUNV and BUNdelNSs virus
displayed similar dose-response curves to IFN (Fig. 2A). Fur-
thermore, the impact of PKR on virus growth in cell culture
(Fig. 2B) and of PKR and 2-5 OAS on disease progression in
experimental animals (Fig. 3) was independent of the presence
of NSs. Thus, unlike other IFN antagonists such as E3L of
vaccinia virus (25) and NS1 of FLUAV (10), BUNV NSs ap-
pears to function exclusively at the level of induction of IFN by
virally produced dsRNA without affecting activation of the
dsRNA-dependent enzymes PKR and 2-5 OAS. In passing, we
have been unable to demonstrate specific binding of BUNV
NSs to dsRNA-coated Sepharose beads (F. Weber, unpub-
lished results).
An unexpected feature of BUNV multiplication is that PKR
is activated (Fig. 1) but does not have an apparent impact on
virus growth in cell culture (Fig. 2B). Some protective effect
was observed in the animal model (Fig. 3), but here also PKR
was not the factor determining whether mice succumbed to
infection or not. In line with these results, the highly related La
Crosse virus is resistant to PKR in vivo (H. P. Hefti and J.
Pavlovic, personal communication). Thus, these bunyaviruses
are different from FLUAV and VSV, the best characterized
negative-stranded RNA viruses with respect to PKR inhibition.
For both of these viruses, it has been shown that PKR signif-
icantly contributes to the antiviral effect of IFN in cell culture
and in mice. For FLUAV, growth of an NS1-deficient mutant
in IFN-competent cells could be rescued to some extent by
FIG. 3. Virulence of bunyaviruses in 129 wt, PKR(/), and
RNase L(/) mice. Groups of six 5-week-old specific-pathogen-free
female mice (kindly obtained from Jovan Pavlovic, University of Zu-
rich, Switzerland) were inoculated intracerebrally with 1,000 PFU of wt
BUN (A) or BUNdelNSs (B) viruses. The animals were monitored
twice daily over an 8-day period. Mice that were moribund or severely
paralyzed were killed and scored dead on the day these symptoms were
observed.
TABLE 1. Virus growth in brains of wt mice and PKR (/) mice
Virus Mice Titers (PFU/ml)a
wt wt 1.5  106
PKR(/) 1.7  106
BUNdelNSs wt 6  104
PKR(/) 1.4  106
a Mice were sacrificed at day 3 postinfection.
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inhibiting PKR, and the mutant virus was able to grow in
PKR(/) mice but not in wt mice (2). Similarly, wt FLUAV
was able to kill 100% of PKR(/) mice, whereas less than
40% of wt mice succumbed to infection (1). For VSV, IFN-
mediated growth inhibition was more pronounced in cells ex-
pressing PKR than in the PKR(/) counterpart, and
PKR(/) mice succumbed to infection, whereas PKR-ex-
pressing mice survived (1, 21). Thus, despite the similarities of
FLUAV and VSV to BUNV with respect to the genetic ma-
terial (negative-stranded RNA), the segmented genome
(FLUAV), and the cytoplasmic location of RNA synthesis
(VSV), bunyaviruses appear to be partially resistant to PKR
action. In addition, BUNV appears to be even more insensitive
to the 2-5 OAS system (Fig. 3) which is also activated by
dsRNA. To our knowledge, no report exists to date to dem-
onstrate the interaction of bunyaviruses with these parts of the
IFN response.
In summary, our studies demonstrate that the bunyavirus
NSs virulence factor is different from other IFN antagonists,
since it inhibits dsRNA-dependent IFN induction but has no
effect on dsRNA-activated PKR. In addition, we showed that
bunyaviruses are not highly sensitive to the antiviral effect of
PKR and 2-5 OAS. Characterization of the interaction of bu-
nyaviruses with the IFN system may help to better understand
virus-host cell interactions and to find means for controlling
the spread of the hazardous members of the Bunyaviridae fam-
ily.
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